Elsa F Mateus Selected Research

Elsa F Mateus Research Topics

9	COVID-19 08/2023 - 01/2021
3	Vasculitis (Vasculitides) 08/2023 - 12/2021
2	Rheumatoid Arthritis 08/2023 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 08/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Rheumatic Diseases (Rheumatism) 10/2021 - 01/2020
2	Necrosis 01/2021 - 01/2020
1	Neoplasms (Cancer) 01/2023
1	Disease Progression 10/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022
1	Joint Diseases (Joint Disease) 01/2022
1	Giant Cell Arteritis (Horton Disease) 12/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2021
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2021
1	Systemic Vasculitis 12/2021
1	Obesity 12/2021
1	Lung Diseases (Lung Disease) 01/2021

5	GlucocorticoidsIBA 08/2023 - 01/2020
4	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2021
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2021
2	Tumor Necrosis Factor InhibitorsIBA 08/2023 - 10/2021
2	ORALIT (ORS)IBA 01/2023 - 12/2021
2	VaccinesIBA 04/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2023
1	Monoclonal AntibodiesIBA 10/2022
1	COVID-19 VaccinesIBA 04/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2021
1	Immunomodulating AgentsIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2020

2	Therapeutics 08/2023 - 10/2021